促进马来西亚高危青少年心理健康(MyHeRo):一项整群随机对照试验的研究方案,评估学校干预相较学习技能条件对焦虑和抑郁高危青少年的有效性及成本效果
该整群随机对照试验将在马来西亚至少20所经济贫困地区中学招募12-14岁青少年,经DASS-21筛查后纳入428名中重度焦虑抑郁者,按1:1随机分配至Super Skills for Life(SSL)学校干预组或学习技能项目(SSP)对照组,评估12个月后焦虑抑郁症状及心理健康改善与成本效果。
要点
- 整群随机对照试验,以班级为随机单位,按学校规模、班级/年级和城乡位置分层。
- 计划纳入至少20所中学的428名12-14岁中重度焦虑抑郁青少年(每臂214人)。
- 主要结局为干预后12个月焦虑和抑郁症状减轻及心理健康改善。
核心结论
- 该试验将确定由学校教职员为焦虑抑郁高危青少年提供团体学校干预是否有效且具成本效果。
- 研究结果将增进对学校教职员在实施学校干预中作用的理解,并产生关于社会文化及其他情境因素预测干预接受度和治疗结局的新知识。
研究设计与样本
- 两臂、整群随机对照试验,比较学校干预Super Skills for Life(SSL)与学习技能对照条件Study Skills Programme(SSP),按1:1分配。
- 以班级为随机单位,按学校规模、班级/年级和学校位置(城市对农村)三个因素分层随机。
- 在马来西亚至少20所经济贫困的城市和农村地区中学招募青少年,经抑郁焦虑压力量表-21(DASS-21)筛查。
- 基于功效计算,纳入DASS-21中重度焦虑和抑郁的428名青少年(每臂214人)。
- 评估在筛查时、干预前(基线)、干预后(2个月)及干预后6个月和12个月两个随访点进行。
关键数值与推荐
- 主要结局为干预后12个月焦虑和抑郁症状减轻及心理健康改善。
- DASS-21筛查中重度焦虑和抑郁的青少年方可纳入试验。
- 随机化采用三个分层因素:学校规模、班级/年级和学校位置(城市对农村)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Malaysia, adolescent anxiety and depression are increasing faster than ever, and rates of suicidal behaviour are rising especially among those living in deprived communities. However, Malaysia's mental health system is currently constrained by limited workforce capacity, affecting the delivery of effective interventions. The overall aim of this trial is to use a school-based intervention to promote mental health among at-risk adolescents from low-income communities in Malaysia. Our primary aim is to evaluate the effectiveness and cost-effectiveness of a school-based intervention ("Super Skills for Life"; SSL) in reducing anxiety and depression, and in improving mental wellbeing in adolescents aged 12-14 years. We also aim to determine the characteristics of adolescents who benefit from SSL, compared to those who do not, as well as to identify contextual factors related to the successful implementation of SSL in Malaysian schools. METHODS: The design will be a two-arm, cluster randomised controlled trial comparing school-based intervention (Super Skills for Life; SSL) to study skills control condition (Study Skills Programme; SSP) using a 1:1 allocation ratio. Classrooms will be the cluster unit for randomisation. Three stratification factors will be used for randomisation: school size, classes/forms and school location (urban vs rural). The study will recruit adolescents in at least 20 secondary schools in economically deprived, rural and urban regions in Malaysia. These adolescents will be invited to complete a screening questionnaire (i.e. Depression Anxiety and Stress Scale-21; DASS-21). Based on power calculation, 428 adolescents (214 per arm) who experience moderate to severe levels of anxiety and depression on the DASS-21 will be invited to participate in the trial. Classes will be randomly allocated to SSL or SSP, with eligible adolescents from each class receiving the allocated intervention. Assessment will be conducted at screening, at pre- (i.e. baseline) and post-intervention (i.e. 2 months), and at two follow-ups (i.e. 6 and 12 months post-intervention). The primary outcomes will be a reduction in anxiety and depressive symptoms, and an improvement in mental wellbeing at 12 months post-intervention. DISCUSSION: Findings of this trial will determine if delivering a group school-based intervention by school staff for adolescents at risk of anxiety and depression is effective and cost-effective. The findings will advance understanding of the role of school staff in the delivery of a school-based intervention and will generate new knowledge on the role of socio-cultural and other contextual factors in predicting intervention uptake and treatment outcome. TRIAL REGISTRATION: ClinicalTrials.gov NCT07138664. Registered on August 16, 2025.
引用
- Essau CA, Zakaria S, Ting CH, et al. Promoting mental health among at-risk adolescents in Malaysia (MyHeRo): study protocol for a cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of a school-based intervention compared with study skills condition for adolescents identified as at risk for anxiety and depression. Trials. 2026. PMID: 41593785. doi:10.1186/s13063-025-09368-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。